Global pharma major Lupin Limited on Monday announced the acquisition of Huminsulin in India from Eli Lilly and Company (Lilly) to further enhance its diabetes portfolio. “The Huminsulin range ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback